• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition

Advantages and regulatory acceptance of RMMs within the industry

Time:June 05-05, 2014

Organizer:European Pharmaceutical Review (EPR)

  • Share on Facebook
  • Tweet
  • Post to Tumblr
  • Pin it
  • Add to Pocket
  • Submit to Reddit
  • Share on LinkedIn
  • Publish on WordPress
  • Save to Pinboard
  • Send email

Validation of rapid methods continues to be an obstacle to greater adoption of these technologies. Some of the benefits of rapid methods are well articulated across industry literature, including the ability to release products much faster as well as intervene faster in the event of contamination in any part of the manufacturing process. Regulatory approval and the challenge of actually validating the rapid method for many applications continue to be viewed as stumbling blocks.
 

Tel:400-610-1188

E-mail:cphiservice@ubmsinoexpo.com

Previous:A flow cytometry based rapid method and the various applications that can be performed

Next:Transforming a paper-based trial master file to a streamlined electronic document management solutio

E-trade 2022_Vitamin
CPHI China E-Learn Series
Virtual Expo Connect 2022 Dec.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service